Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Disease-specific tools better assess quality of life in alopecia areata patients.

Unmodified fullerene C60 promotes hair growth and may help treat hair loss.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

miR-155-5p can help diagnose and track alopecia areata severity.

Targeting regulatory T cells may help treat age-related diseases.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Alopecia areata patients may have hearing loss linked to the condition's severity and duration.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Machine learning can help find new ways to treat alopecia areata.

Gut bacteria differences could help diagnose and treat alopecia areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Identifying and treating deficiencies and conditions can stop or reverse premature greying in children.

Identifying and treating deficiencies and conditions can stop or reverse premature greying in children.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Hair follicles prevent NK cell attacks to avoid hair loss.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.